512
Views
11
CrossRef citations to date
0
Altmetric
Author's View

Chemotherapeutic targeting of myeloid-derived suppressor cells

, &
Article: e27359 | Received 25 Nov 2013, Accepted 27 Nov 2013, Published online: 01 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alexandre Abilio S. Teixeira, Luana Amorim Biondo, Loreana S. Silveira, Edson A. Lima, Helena A. Batatinha, Tiego A. Diniz, Camila Oliveira De Souza, Jeferson Comin & José Cesar Rosa Neto. (2020) Doxorubicin modulated clock genes and cytokines in macrophages extracted from tumor-bearing mice. Cancer Biology & Therapy 21:4, pages 344-353.
Read now
Fei Geng, Xin Bao, Ling Dong, Qian-Qian Guo, Jie Guo, Yu Xie, Yi Zhou, Bin Yu, Hui Wu, Jia-Xin Wu, Hai-Hong Zhang, Xiang-Hui Yu & Wei Kong. (2020) Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model. OncoImmunology 9:1.
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now

Articles from other publishers (8)

Antonio Giovanni Solimando, Angelo Vacca & Domenico Ribatti. (2020) A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche. Journal of Oncology 2020, pages 1-16.
Crossref
Robin Parihar, Charlotte Rivas, Mai Huynh, Bilal Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen M. Gottschalk & Cliona M. Rooney. (2019) NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Cancer Immunology Research 7:3, pages 363-375.
Crossref
Manuchehr Abedi-Valugerdi, Wenyi Zheng, Fadwa Benkessou, Ying Zhao & Moustapha Hassan. (2017) Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice. International Immunopharmacology 47, pages 173-181.
Crossref
Chris G. TwittyOscar R. DiagoDaniel J. HoganCindy BurrascanoCarlos E. IbanezDouglas J. JollyDerek Ostertag. (2016) Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types. Human Gene Therapy Methods 27:1, pages 17-31.
Crossref
Morteza Motallebnezhad, Farhad Jadidi-Niaragh, Elmira Safaie Qamsari, Salman Bagheri, Tohid Gharibi & Mehdi Yousefi. (2015) The immunobiology of myeloid-derived suppressor cells in cancer. Tumor Biology 37:2, pages 1387-1406.
Crossref
Salman M Toor & Eyad Elkord. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 8 .
Xiang Huang, Dan Guan, Yong-Qian Shu, Lian-Ke Liu & Fang Ni. (2015) Effect of Cisplatin on the Frequency and Immuno-inhibitory Function of Myeloid-derived Suppressor Cells in A375 Melanoma Model. Asian Pacific Journal of Cancer Prevention 16:10, pages 4329-4333.
Crossref
Cirino Botta, Annamaria Gullà, Pierpaolo Correale, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2014) Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities. Frontiers in Oncology 4.
Crossref